Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06787274 · ClinicalTrials.gov registry record

Research on Equity in Abortion Care by TeleHealth

A clinical trial of Abortion in First Trimester and Abortion Early, sponsored by University of California, San Francisco.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT06787274: Recruiting study of Abortion in First Trimester and Abortion Early, sponsored by University of California, San Francisco.

NCT06787274 is a study of Abortion in First Trimester and Abortion Early that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, above the 132-participant average among 3 other Abortion in First Trimester trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06787274, a study of Abortion in First Trimester and Abortion Early, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested, eligible participants: 2,000 patients seeking abortion care will complete the study, comprising of 2 groups: patients seeking medication abortion care either (1) in-person or (2) via telehealth. This project will address how telehealth services can be optimized for people of color, low-income people, and immigrants to increase digital inclusion and health equity.

Primary Outcome

Descriptive statistics for the elapsed days from the first pregnancy test to 1) date of the decision to have an abortion, 2) date of first contact with the clinic, 3) date of medication receipt, and 4) date mifepristone (the first medication) was ingested.

Study Locations (1)

California

  • Advancing New Standards in Reproductive Health (ANSIRH) - Oakland

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2025-02-12
Est. Completion 2027-03-31

What NCT06787274 shows while recruiting

NCT06787274 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 132-participant average among 3 other Abortion in First Trimester trials with a reported enrollment target (1415% higher).

The record links to 3 conditions, with Abortion in First Trimester appearing as the primary indexed condition, and to 0 interventions.

NCT06787274 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06787274 about?

NCT06787274 is a clinical study titled "Research on Equity in Abortion Care by TeleHealth". This study will examine the ways in which telehealth for reproductive healthcare affects timing, costs, and follow-up care; whether telehealth reaches people in areas with greater health inequities; and the attributes of telehealth that patients want. Study surveys will be administered to interested...

What is the current status of trial NCT06787274?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-02-12. Estimated completion is 2027-03-31.

What conditions does trial NCT06787274 study?

This clinical trial studies the following conditions: Abortion in First Trimester, Abortion Early, Abortion; Attempted.

Who is sponsoring clinical trial NCT06787274?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06787274 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abortion in First Trimester

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06787274, the US trial registry maintained by the National Library of Medicine. NCT06787274 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.